Sell 2/11/2025Downgrade
Conduit Pharmaceuticals Inc. (CDT) was downgraded to E+ from D- on 2/11/2025 due to a noticeable decline in the volatility index and total return index.

Sell 1/27/2025Upgraded
Conduit Pharmaceuticals Inc. (CDT) was upgraded to D- from E+ on 1/27/2025 due to an increase in the volatility index and valuation index.

Sell 1/19/2024Downgrade
Conduit Pharmaceuticals Inc. (CDT) was downgraded to E+ from D on 1/19/2024 due to a major decline in the efficiency index, growth index and valuation index.

Sell 11/24/2023Upgraded
Conduit Pharmaceuticals Inc. (CDT) was upgraded to D from E+ on 11/24/2023 due to a significant increase in the solvency index, efficiency index and growth index. Debt to equity declined from -0.31 to -0.91, net income increased 179.19% from -$2.51M to $1.99M, and total capital increased 99.06% from -$10.64M to -$100.

Sell 10/13/2023Downgrade
Conduit Pharmaceuticals Inc. (CDT) was downgraded to E+ from D- on 10/13/2023 due to a noticeable decline in the solvency index, total return index and valuation index.

Sell 10/4/2023None
Conduit Pharmaceuticals Inc. (CDT) was downgraded to D- from U on 10/04/2023.